Summary
The first case in Ireland of the Lesch-Nyhan syndrome is reported. Less than 200 are known worldwide. The clinical and biochemical presentations of this patient are classical. His hyperuricaemia is being controlled satisfactorily by allopurinol, his general health being thus maintained as well as his neurological condition allows. Gouty arthritis and tophaceous deposition of urate have been prevented to date. Pharmacological treatments of his various neurological and behavioural abnormalities have not been successful.
References
Di Chiara, Cambria, R. and Spano, P. F. 1971. Evidence for inhibition by brain serotonin of mouse killing behaviour in rats. Nature 233, 272.
Kelley, W. N. and Wyngaarden, J. B. 1972. The Lesch-Nyhan syndrome.In The Metabolic Basis of Inherited Disease, ed. by J. B. Stanbury, J. B. Wyngaarden and D. S. Fredrickson. New York. McGraw-Hill. p. 969.
Lesch, M. and Nyhan, W. L. 1964. A familial disorder of uric acid metabolism and central nervous system function. Amer. J. Med. 36, 561.
Mizuno, T. and Yugari, Y. 1974. Self mutilation in Lesch-Nyhan syndrome. Lancet i, 761.
Scherzer, A. L. and Ilson, J. B. 1969. Normal intelligence in the Lesch-Nyhan syndrome. Pediatrics 44, 116.
Seegmiller, J. E., Rosenbloom, F. M. and Kelley, W. N. 1967. An enzyme defect associated with a sex linked human neurological disorder and excessive purine synthesis. Science 155, 1682.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, R.G.G., Buckley, B.M. & Tully, E.R. Clinical and biochemical observations on a patient with the Lesch-Nyhan syndrome. I.J.M.S. 147, 213–215 (1978). https://doi.org/10.1007/BF02939405
Issue Date:
DOI: https://doi.org/10.1007/BF02939405